http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2503458-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95caa84fad93b9d0ab839966fbb05fb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d3696da2c84988ebfc187f8ef6e60e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9007702cfb8d7c8914b1104d511fa507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_836c1aeb9011d8d91d381772f5f1ac74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2fd692e0e5b49effbdb70386391574bb
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02
filingDate 2012-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12b6116a216dd10c4cabcaa9825d84a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddaba3d549d9e15b4e9e1c4524751f40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7852fc9039d4ae4424ed0df45c5efa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_447be525fef9be46e8687d402c15f51c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95e45c5087161c9b66b97ad0452eb4ec
publicationDate 2014-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2503458-C1
titleOfInvention Method of local treatment and prevention of primary dental diseases in children with chronic renal pathology using chewable phytosubstrate
abstract FIELD: medicine. n SUBSTANCE: invention refers to medicine, particularly to dentistry, and may be used for the local treatment and prevention of the primary dental pathologies in hemodialysis-dependent children suffering a terminal stage of the chronic renal failure. That is ensured by using a chewable substrate containing bee wax 4.0 g and cultivated angelica root 0.4 g 3 times a day for 15 minutes for 2 weeks. n EFFECT: method enables improving and stabilising the clinical measures of the active products of the oral fluid due to a synergetic effect of the substrate components. n 4 tbl, 1 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2687977-C1
priorityDate 2012-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7160862-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2303451-C2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440968
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426106353
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID40949
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18291
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID40949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457630696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433298
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID52462
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID52462

Total number of triples: 34.